# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 18.9% Upside Potential

- Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-18.9-upside-potential/4121135138
- Published: 2023-12-05T13:43:41+00:00
- Author: Charlotte Edwards

**GE HealthCare Technologies Inc.** with ticker code (GEHC) have now 12 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The range
between the high target price and low target price is between $97.00 and $66.00 
calculating the average target price we see $82.54. Given that the stocks previous
close was at $69.41 this would indicate that there is a potential upside of 18.9%.
It’s also worth noting that there is a 50 day moving average of $68.38 and the 200
day MA is $74.49. The market cap for the company is 31.58B. The current share price
for the company is: $69.37 USD

 The potential market cap would be $37,554,105,509 based on the market consensus.

The company has a dividend yield of 0.77%. Other points of data to note are a P/
E ratio of 20.58, revenue per share of $42.36 and a 6.17% return on assets.

GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics,
and digital solutions company. The Company develops, manufactures, and markets a
portfolio of products, services, and complementary digital solutions used in the
diagnosis, treatment, and monitoring of patients. The Company’s segments include
Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The 
Imaging segment includes scanning devices, clinical applications, service capabilities
and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment,
and monitoring of certain diseases. The Patient Care Solutions segment includes 
medical devices, services, consumable products, services, and digital solutions.
The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the
global radiology and nuclear medicine industry.

Share on: